Group 1 - The Hong Kong Technology ETF (513560) has shown strong performance, with a recent increase of 1.96% and a trading volume of 60.53 million yuan, indicating active market participation [2] - The index it tracks, the CSI Hong Kong Stock Connect Technology Index (931573), has seen significant gains, with notable increases in constituent stocks such as Innovent Biologics (01801) up 16.22% and Zai Lab (09688) up 7.45% [2] - The average daily trading volume of the Hong Kong Technology ETF since the beginning of 2025 is 445 million yuan, reflecting robust trading activity [2] Group 2 - The Hong Kong Technology ETF has reached a new high in scale at 524 million yuan, with a recent increase of 16 million shares over the past week, ranking second among comparable funds [3] - Over the past year, the net value of the Hong Kong Technology ETF has increased by 59.78%, placing it first among comparable funds [3] - The ETF has demonstrated a historical return capability, with a maximum monthly return of 26.15% and an average monthly return of 8.83% [3] Group 3 - The Hong Kong Technology ETF has a management fee of 0.50% and a custody fee of 0.10%, contributing to its overall cost structure [4] - The ETF's tracking error over the past three months is 0.213%, indicating the highest tracking precision among comparable funds [4] - The current price-to-earnings ratio (PE-TTM) of the CSI Hong Kong Stock Connect Technology Index is 21.9, which is below 94.42% of the historical data over the past year, suggesting a low valuation [4] Group 4 - The top ten weighted stocks in the CSI Hong Kong Stock Connect Technology Index account for 71.48% of the index, with major companies including Xiaomi (01810), BYD (01211), and Alibaba (09988) [4] - Investors without stock accounts can access the Hong Kong Technology ETF through linked funds, providing an opportunity to invest in the innovative pharmaceutical sector [6]
生物医药板块表现强势，香港科技ETF(513560)高开高走涨近2%